In Figure 1C on page 479 in the 11 February 2020 issue, the x-axis label “2” should read “7.” The corrected figure panel is shown below. The error has been corrected in the published article.
© 2020 by The American Society of Hematology
2020
Advertisement intended for health care professionals
Carden MA, Gaddh M, Hoskote A, et al. Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx. Blood Adv. 2020;4(3):477-481.. Blood Adv 2020; 4 (6): 1093. doi: https://doi.org/10.1182/bloodadvances.2020001818
Download citation file:
In Figure 1C on page 479 in the 11 February 2020 issue, the x-axis label “2” should read “7.” The corrected figure panel is shown below. The error has been corrected in the published article.
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals
Advertisement intended for health care professionals